BROADCASTS.com

Dr. Thomas Dayspring joins me again today for the third class in our Lipid Masterclass Series. Dr. Dayspring brings a wealth of expertise as a certified specialist in internal medicine and clinical lipidology, holding fellowships with the American College of Physicians and the National Lipid Association.\nThis hour-long class is devoted to women's health and abnormal lipids. We continue with our conversation about ApoB, discussing ways to look at other lipid abnormalities related to abnormal ApoBs and talking about our ideal lab values and lifestyle modifications, briefly touching on my lipid journey and the medication I have been taking for the past six months. We examine diagnostics and their limitations, getting into CACs, coronary artery calcification scoring, CIMT, the labs we need to look at, the role of Lp(a), and how it affects our heart. We look into the changes women experience from losing estrogen in menopause, clues women can use to predict future cardiovascular risk, how estrogen helps clear LDL from the body, and the changes occurring with menopause, including higher ApoBs. We also dive into risks women face for cardiovascular disease, the impact of the Women's Health Initiative study, and absorption and synthesis challenges with cholesterol.\nStay tuned for more!\n\nIN THIS EPISODE YOU WILL LEARN:\n\nWhy ApoB testing for inherited lipoprotein disorders is essential\xa0\n\nWhy hypo beta lipoproteins (HDL) are critical for maintaining good health\n\nThe benefits of a holistic approach to treating high cholesterol\n\nThe three stages of prevention for atherosclerosis\n\nHow Lp(a) impacts heart health\n\nThe importance of assessing early heart function through Lp(a) testing\n\nHow your pregnancy history can help in predicting your risk for cardiovascular disease\n\nWhy should women be more concerned about cardiovascular disease than breast cancer?\n\nHow the Women\u2019s Health Initiative led gynecologists to be more cautious about prescribing HRT\n\nHow genetically mediated cholesterol abnormalities can impact our ability to absorb and synthesize cholesterol\n\n\xa0\nBio:\nThomas Dayspring MD is a Fellow of both the American College of Physicians and the National Lipid Association and is certified in internal medicine and clinical lipidology. After practicing in New Jersey for 37 years, in 2012, he moved to Virginia to serve as an educational director for a nonprofit cardiovascular foundation until mid-2019 as a Chief Academic Advisor for two major CV laboratories. Since then, he has served as a virtual cardiovascular / lipidology educator. Career-wise he has given over 4000 domestic (in all 50 states) and several international lectures, including over 600 CME programs on atherothrombosis, lipids/lipoproteins (and their treatment), vascular biology, biomarker testing, and women\u2019s cardiovascular issues. He has authored several manuscripts and lipid textbook chapters and performed several podcasts. For several years, he was an Associate Editor of the Journal of Clinical Lipidology. He was the recipient of the 2011 National Lipid Association\u2019s Presidents Award for services to clinical lipidology and the 2023 Foundation of NLA Clinician/Educator Award. He has over 34K followers on his educational Twitter (X) feed (@Drlipid). He has Gold Heart Member status as a professional member of the American Heart Association, and he serves as a Social Media Ambassador for the European Atherosclerosis Society and the National Lipid Association.\n\nConnect with Cynthia Thurlow\n\nFollow on Twitter\n\n\nInstagram\n\nLinkedIn\n\nCheck out Cynthia\u2019s website\n\n\nSubmit your questions to support@cynthiathurlow.com\n\n\n\n\ufeffConnect with Dr. Thomas Dayspring\n\nOn Twitter (@DrLipid)\n\nLinkedIn